Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F73XN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,258
Award facts
- Contract value 100% obligated
- $1,257.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,257.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on January 12, 2026, with ultimate completion by January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999.99 million through December 31, 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has demonstrated capability to fulfill federal medical procurement requirements through multiple competitive awards. The company's contract portfolio with DLA encompasses diverse therapeutic categories including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for NURTEC ODT, a migraine treatment medication, exemplifies the routine pharmaceutical supply operations supporting Department of Defense healthcare systems, military treatment facilities, and other federal medical institutions through AmerisourceBergen's established prime vendor relationship with the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F73XN?
SPE2DR26F73XN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F73XN worth?
The government has obligated $1,258 on SPE2DR26F73XN.
Is contract SPE2DR26F73XN an order under another contract?
Yes. SPE2DR26F73XN is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73XN competed?
The extent of competition for SPE2DR26F73XN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award